Treatment of Generalized Pruritus
Start all patients with generalized pruritus with self-care advice and emollients as the foundation of therapy, regardless of the underlying cause. 1, 2
Initial Management Algorithm
Step 1: Rule Out Underlying Causes First
Before treating symptomatically, investigate for systemic disease with these essential tests 1:
- Complete blood count (evaluate for hematologic malignancy) 1, 3
- Liver function tests and serum bile acids (cholestatic disease) 1, 3
- Renal function: creatinine and blood urea nitrogen (uremic pruritus) 1, 3
- Thyroid-stimulating hormone (thyroid disorders) 1, 3
- Ferritin (iron metabolism disorders) 1
- Fasting glucose (diabetes mellitus) 1, 3
- Chest X-ray if lymphoma suspected (Hodgkin disease causes pruritus in 30% of cases) 1, 3
Step 2: First-Line Topical Therapy
All patients should receive emollients immediately while awaiting diagnostic workup 1, 2:
- High lipid content moisturizers are preferred, especially in elderly patients 1, 2
- Add topical clobetasone butyrate or menthol preparations for additional relief 1, 2
- Topical doxepin can be used but strictly limit to 8 days, maximum 10% body surface area, and 12g daily maximum 1, 2
Important caveat: In elderly patients specifically, use emollients PLUS topical steroids for at least 2 weeks to exclude asteatotic eczema before proceeding further 1, 2
Avoid these topical agents as they are ineffective or harmful 1:
Step 3: Second-Line Oral Antihistamines
If topical therapy fails after 2 weeks, add non-sedating antihistamines 1, 2:
- Fexofenadine 180 mg daily OR loratadine 10 mg daily are preferred first choices 1, 2
- Cetirizine 10 mg daily is acceptable as a mildly sedative alternative 1, 2
- Consider combining H1 and H2 antagonists (e.g., fexofenadine + cimetidine) for enhanced effect 1
Critical warning: Sedative antihistamines like hydroxyzine should ONLY be used short-term or in palliative settings due to dementia risk, and should be completely avoided in elderly patients (Strength of recommendation C) 1, 2, 4
Step 4: Third-Line Systemic Medications
When antihistamines fail, escalate to these agents 1, 2:
Neuromodulators (choose one):
- Gabapentin (effective in elderly and neuropathic pruritus, but avoid in hepatic pruritus) 1, 2, 5
- Pregabalin 1, 2
Antidepressants (choose one):
Opioid receptor modulators:
Other options:
Disease-Specific Modifications
If Hepatic Pruritus Identified:
- Rifampicin is first-line 2
- Cholestyramine second-line 2
- Sertraline third-line 2
- Never use gabapentin in hepatic pruritus 2
If Uremic Pruritus Identified:
- Optimize dialysis, normalize calcium-phosphate balance, control parathyroid hormone, correct anemia 2
- BB-UVB phototherapy is highly effective (Strength of recommendation A) 2
- Continue emollients 2
If Drug-Induced Pruritus:
For opioid-induced pruritus: Naltrexone is first-choice if opioid cessation impossible (Strength of recommendation B); methylnaltrexone is alternative 1, 2
For postoperative pruritus: Diclofenac 100 mg rectally 1, 2
For chloroquine-induced pruritus: Prednisolone 10 mg, niacin 50 mg, or combination; dapsone is alternative 1
When to Refer to Secondary Care
Refer immediately if 1:
- Diagnostic uncertainty exists 1
- Primary care management fails to relieve symptoms 1
- Patient is significantly distressed 1
- Elderly patients not responding to initial 2-week trial 1
Adjunctive Non-Pharmacologic Options
Consider as second-line complementary therapy 1:
- Acupuncture (alone or with Chinese herbal remedies) 1
- Behavioral interventions, relaxation techniques, cognitive restructuring for suspected psychogenic component 1, 2
- Patient support groups 1, 2
Common Pitfalls to Avoid
- Never use sedative antihistamines long-term outside palliative care—dementia risk outweighs benefits 1, 2
- Don't exceed topical doxepin limits (8 days, 10% BSA, 12g daily) due to systemic absorption risk 1, 2
- Don't forget to reassess elderly patients who fail initial therapy—may have occult bullous pemphigoid 1
- Ensure continuous follow-up when cause is not immediately evident, as systemic disease may emerge later 1